Is Anebulo Pharmaceuticals, Inc. (ANEB) a Buy, Sell, or Hold?
OTC : ANEB
Anebulo Pharmaceuticals, Inc. — Institutional Ownership
$0.3 USD
$0.0 (-1.45%)
- Volume
- 0
- Average Volume
- 2.61K
- Market Capitalization
- $12.24M
- P/E Ratio
- -1.54
- Dividend Yield
- 0.00%
- Price Target
- $6.00
- Year High
- $2.90
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $16.71
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-02-13 | Nantahala Capital Management, LLC | 3.55M | 8.53% |
| 2025-03-17 | Mangrove Partners IM, LLC | 2.53M | 6.15% |
| 2025-02-27 | Aron R. English | 21.93M | 51.10% |
| 2025-02-27 | 22 NW FUND, LP | 17.17M | 40.10% |
| 2025-02-27 | PHARMA INVESTORS, LLC | 4.65M | 11.30% |
| 2025-02-14 | Nantahala Capital Management, LLC | 3.55M | 8.63% |
ANEB Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-06-30 | $1.44 | 33.82M | $48.7M | $11.63M | -$ | $37.07M |
| 2024-06-30 | $2.68 | 25.82M | $69.2M | $3.09M | -$ | $66.11M |
| 2023-06-30 | $2.35 | 25.07M | $58.92M | $11.25M | -$ | $47.68M |
| 2022-06-30 | $5.20 | 23.34M | $121.39M | $14.55M | -$ | $106.85M |
| 2021-06-30 | $6.82 | 23.34M | $159.21M | $19.99M | -$ | $139.23M |
| 2020-06-30 | $7.10 | 23.72M | $168.39M | $3.02M | $201.29K | $165.56M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $1.01 | 41.08M | $41.5M | $9.04M | -$ | $32.45M |
| 2025-09-30 | $2.50 | 41.08M | $102.71M | $10.35M | -$ | $92.36M |
| 2025-06-30 | $1.44 | 41.08M | $59.16M | $11.63M | -$ | $47.53M |
| 2025-03-31 | $1.30 | 27.42M | $35.64M | $13.28M | -$ | $22.36M |
| 2024-12-31 | $1.68 | 27.42M | $46.06M | $15M | -$ | $31.06M |
| 2024-09-30 | $1.93 | 25.93M | $50.05M | $1.4M | -$ | $48.65M |
| 2024-06-30 | $2.68 | 25.82M | $69.2M | $3.09M | -$ | $66.11M |
| 2024-03-31 | $2.89 | 25.93M | $74.95M | $5.15M | -$ | $69.8M |
| 2023-12-31 | $2.42 | 25.79M | $62.41M | $6.64M | -$ | $55.77M |
| 2023-09-30 | $3.06 | 25.63M | $78.31M | $8.52M | -$ | $69.79M |
| 2023-06-30 | $2.35 | 25.07M | $58.92M | $11.25M | -$ | $47.68M |
| 2023-03-31 | $2.90 | 25.63M | $74.34M | $14.16M | -$ | $60.17M |